washed with brine (~50 mL). Organic phase was then dried over Na2SO4, and concentrated in vacuo. Residue was recrystallized in ethanol to yield 1.4 g of product as yellow needle crystals. Yield: 82%. 1 H NMR (CDCl3) δ 8. 2H), 7.81 (dd, J = 8.1, 0.4 Hz, 1H), 7.75 (dd, J = 8.0, 0.6 Hz, 1H), 1H), 2H), 1H), 1H) , 4.98 (s, 2H) ppm. 13 C NMR (CDCl3) δ 193.0, 165.2, 152.9, 135.6, 133.9, 128.8, 128.6, 126.1, 124.4, 121.5, 121.1, 41 .0 ppm. HRMS (ESI): calcd. for C15H11NOS2Na + [M+Na] + 308.0174, found 308.0189.
2-(Benzo[d]thiazol-2-ylthio)-1-phenylpropan-1-one (5b)
To a solution of 2-mercaptobenzothiazole (334 mg, 2 mmol) in 4 mL DCM was added triethylamine (TEA, 0.39 mL, 2.8 mmol). The 2-bromopropiophenone (0.30 mL, 2 mmol) was added dropwise. The reaction mixture was stirred at room temperature for 1 h and then dried under vacuum. The residue was re-dissolved in 10 mL EA and washed with water (10 mL  2). Water phase was back extracted with 15 mL EA. Combined organic phase was dried over Na2SO4, concentrated in vacuo, and purified by column chromatography (EA/Hex 1:20 to 1:10). Product (470 mg) was obtained as yellow oil. Yield: 78%. 1 NMR (CDCl3) δ 197.3, 164.7, 152.9, 135.7, 135.0, 133.6, 128.9, 128.8, 126.1, 124.5, 121.6, 121.1, 47.1, 18.3 
2-(Benzo[d]thiazol-2-ylthio)-2-methyl-1-phenylpropan-1-one (5c)
A solution of 2-mercaptobenzothiazole (167 mg, 1 mmol) in 2 mL DCM was added with 0.20 mL TEA (1.4 mmol). To the solution was then added 2-bromo-2-methylpropiophenone (0.17 mL, 1 mmol) dropwise. The reaction mixture was stirred at room temperature for 0.5 h and then heated to 60 o C for 4 h. After cooling to room temperature, solvent was removed by reduced pressure. Residue was re-dissolved in 10 mL EA and washed with water (10 mL  2). Aqueous phase was back extracted with 15 mL EA. Combined organic phase was dried over Na2SO4, concentrated in vacuo, and purified by column chromatography (EA/Hex 1:20 to 1:10). 175 mg product was obtained as yellow oil. Yield: 56%. 1 H NMR (CDCl3) δ 8.13 -8.05 (m, 2H), 7.89 (d, J = 8.1 Hz, 1H), 7.71 (d, J = 8.0 Hz, 1H), 1H), 3H), (m, 1H), 1.86 (s, 6H) ppm. 13 C NMR (CDCl3) δ 200.6, 161.4, 153.1, 136.7, 136.3, 131.8, 129.1, 127.9, 126.1, 125.0, 122.5, 121.0, 58.1, 27.4 
1-(Benzo[d]thiazol-2-ylthio)-3-methylbutan-2-one (5d)
1-Bromo-3-methyl-2-butanone (0.12 mL, 1 mmol) and 2-mercaptobenzothiazole (167 mg, 1 mmol) were dissolved in 5 mL acetone. To the solution was added K2CO3 (138 mg, 1 mmol). The reaction mixture was stirred at room temperature for 1 h then dried under reduced pressure. The residue was re-dissolved in 10 mL EA and washed with water (10 mL  2). The aqueous phase was back extracted with EA (15mL  2). Combined organic phase was dried over Na2SO4 and concentrated over vacuum. The crude product was purified by column chromatography (EA/Hex 1:20 to 1:10 3, 165.3, 152.9, 135.6, 126.1, 124.4, 121.4, 121.1, 41.4, 40.1, 18.4 
2-(Benzo[d]thiazol-2-ylthio)cyclohexan-1-one (5e)
To a solution of 2-mercaptobenzothiazole (500 mg, 3.0 mmol) and trimethylamine (0.58 mL, 4.2 mmol) in 6 mL DCM was added 2-chlorocyclohexan-1-one (0.36 mL, 3.1 mmol) slowly. The solution was heated at reflux for 4.5 h, then cooled to room temperature, and stirred overnight. The reaction mixture was diluted with DCM to 15 mL and washed with water (10 mL  2). The combined aqueous phase was back extracted with DCM (15 mL  2). Combined organic phase was dried over Na2SO4, concentrated in vacuo, and purified by column chromatography (EA/ 5, 164.8, 153.1, 135.5, 126.0, 124.4, 121.6, 121.0, 57.4, 41.6, 35.5, 27.6, 25 
General procedure of reducing β-ketosulfides to β-alkoxysulfides:
Compounds 6a-e were prepared by reducing compounds 5a-e with NaBH4. In general, 1 equiv. of compounds 5a-e was dissolved in MeOH (10~15 mL/mmol) and cooled to 0 °C in an ice bath. NaBH4 (4 equiv.) was added to the solution in small portions. The reaction was then allowed to warm up to room temperature. The reaction process was monitored by TLC. After completion, the reaction was quenched with sat. NH4Cl aqueous solution. The mixture was then extracted with EA and washed with water and brine. The organic phase was dried over Na2SO4 and concentrated under reduced pressure. Crude product was purified by column chromatography.
2-(Benzo[d]thiazol-2-ylthio)-1-phenylethan-1-ol (6a)
Synthesis followed the general procedure of reducing β-ketosulfides to β-alkoxysulfides from 5a. 9, 152.5, 142.9, 135.5, 128.6, 127.9, 126.3, 125.9, 124.7, 121.4, 121.1, 73.6, 42.8 9, 152.5, 142.5, 135.6, 128.4, 127.9, 126.7, 126.3, 124.8, 121.5, 121.1, 78.5, 52.3, 18.3 3, 152.6, 141.0, 136.1, 128.1, 127.7, 127.7, 126.5, 125.2, 121.9, 121.1, 81.7, 60.1, 27.1, 24 
2-(Benzo[d]thiazol-2-ylsulfonyl)-1-phenylethan-1-ol (7a)
Synthesis followed the general procedure of the oxidation of sulfide to sulfone from 6a. Product was obtained as white solid. Yield: 78%. .42 -7.27 (m, 5H), 5.51 (dd, J = 9.7, 1.8 Hz, 1H), 3.94 (dd, J = 14.9, 9.7 Hz, 1H), 3.82 (dd, J = 14.9, 2.1 Hz, 1H), 3.59 (s, 1H) ppm.
13 C NMR (CDCl3) δ 166.3, 152.4, 140.3, 136.7, 128. 9, 128.6, 128.3, 127.9, 125.7, 125.5, 122.4, 68.7, 63.0 
2-(Benzo[d]thiazol-2-ylsulfonyl)-1-phenylpropan-1-ol (7b)
Synthesis followed the general procedure of the oxidation of sulfide to sulfone from 6b. 0, 152.7, 139.5, 136.9, 128.9, 128.8, 128.1, 127.7, 127.1, 125.6, 122.3, 74.0, 66.2, 11.9 164.9, 152.8, 138.0, 137.3, 128.5, 128.2, 128.1, 128.0, 127.8, 125.7, 122.2, 74.8, 70.4, 20.8, 14.4 
2-(Benzo[d]thiazol-2-ylthio)-1-phenylpropyl acetate (8b)
A solution of 6b (100 mg, 0.33 mmol) in 2 mL DCM was treated with Ac2O (0.09 mL, 1 mmol), TEA (0.14 mL, 1 mmol), and N,N-dimethylaminopyridine (DMAP, 4 mg, 0.03 mmol) under stirring at room temperature. After 1 hour, the reaction mixture was directly dried under reduced pressure and purified by column chromatography (EA/Hex 1:20 6, 162. 6, 153.7, 136.9, 136.4, 128.3, 128.2, 127.9, 126.2, 125.1, 122.8, 120.9, 79.7, 56.4, 25.7, 24.3 7, 166.9, 152. 8, 136.7, 136.6, 129.2, 128.9, 128.1, 127.8, 127.6, 125.5, 122.27, 74.9, 62.8, 20. 6, 10.6 7, 165.3, 153.1, 137.3, 135.8, 128.8, 128.4, 128.1, 127.8, 127.7, 125.7, 122.2, 75.7, 69.1, 20.7, 20.3, 16.5 
2-(Benzo[d]thiazol-2-ylsulfonyl)-2-methyl-1-phenylpropyl propionate (11)
Synthesis followed the general procedure of the oxidation of sulfide to sulfone from 11. Product was obtained as clear oil. Yield: 81%. 1, 137.2, 135.9, 128.8, 128.4, 128.1, 127.8, 127.7, 125.7, 122.1, 75.4, 69.1, 27.3, 20.4, 16.5 
2-(Benzo[d]thiazol-2-ylthio)-2-methyl-1-phenylpropyl pivalate (16)
Compound 6c (200 mg, 0.63 mmol) and DMAP (7 mg, 0.06 mmol) were dissolved in 2 mL DCM. To this solution was added TEA (0.18 mL, 1.26 mmol) and pivaloyl chloride (0.09 mL, 0.73 mmol) slowly under stirring. The reaction mixture was heated at 60 °C for 8 hours, then cooled to room temperature, and stirred overnight. The reaction mixture was diluted with 10 mL DCM, and washed with 8 mL water. The aqueous phase was back extracted with DCM (10 mL  2). Combined organic phase was dried over Na2SO4, concentrated in vacuo, and purified by column chromatography (DCM/Hex 1:2 to 1:1 to pure DCM 1, 164.6, 153.2, 137.3, 136.0, 128.8, 128.4, 128.1, 127.9, 127.6, 125.8, 122.2, 74.9, 68.6, 38.8, 26.9, 21.6, 16.4 
2-(Benzo[d]thiazol-2-ylthio)-2-methyl-1-phenylpropyl 2-chloroacetate (17)
Compound 6c (140 mg, 0.44 mmol) was dissolved in 5 mL DCM. To this solution was added TEA (0.11 mL, 0.80 mmol). The solution was cooled to 0 °C in ice bath. 2-Chloroacetyl chloride (0.04 mL, 0.50 mmol) was then added slowly to the solution. The reaction mixture was stirred at 0 °C for 90 min. Then 5 mL water was added into the reaction mixture. The aqueous layer was extracted with DCM (10 mL  3). Combined organic phase was washed with brine, dried over Na2SO4, concentrated, and purified by column chromatography (EA/Hex 1:40 to 1:20 2, 164.7, 153.0, 137.3, 134.8, 129.2, 128.6, 128.3, 127.9, 127.8, 125.7, 122.3, 77.1, 69.0, 40.8, 20.4, 16.3 
2-(Benzo[d]thiazol-2-ylsulfonyl)-2-methyl-1-phenylpropyl dimethylglycinate (13)
Compound 17 (100 mg, 0.24 mmol) was dissolved in 5 mL acetone and added with K2CO3 (66 mg, 0.48 mmol). Dimethylamine (2.0 M in methanol, 0.24 mL, 0.48 mmol) was added into this solution and then the reaction mixture was stirred overnight. Subsequently, the reaction mixture was filtered. 
Confirmation of SO2 release by DTNB test
DTNB test was adopted from a published method. 1 7b and 7c were prepared as 500-μM DMSO stock solutions. DTNB was prepared as 15-mM EtOH stock solution. NaHSO3 as positive control was prepared as a 1-mM PBS (pH 7.4) stock solution and stored on ice before use. 2-OHBT and 2-methyl-1-phenyl-propene as negative controls were prepared as 500-μM DMSO stock solutions respectively. Each group (200 μL total volume) was prepared by adding 20 μL stock solution into the wells of a 96-well plate followed by addition of 180 μL PBS. Each final solution contained 10% DMSO. The plate was incubated at 37 °C for 0.5 h with gentle shaking on a Barnstead shaker. Then 20 μL DTNB was added into each well. After incubating at room temperature for another 15 min, the UV absorption was read by a PerkinElmer multiplate reader at 405 nm (n=3). Figure S1 . DTNB test results. **: p < 0.01.
Kinetics study of compound 7a-e by HPLC
Compounds 7a-d were prepared as 500-μM DMSO stock solution at room temperature. Test solution (50 μM) was prepared in 8 mL glass vial by adding 200 μL of a DMSO stock solution into 1800 μL PBS and the resulting solution was incubated immediately in a water bath at 37 °C. 100
μL of samples for analysis were taken at random time points (n = 10) and were mixed with 300 μL ACN in a 1.5-mL eppendorf tube and stored at -80 °C. Frozen samples were thawed and centrifuged with benchtop microcentrifuge shortly to allow salt precipitation. Supernatant was subjected to HPLC analysis. Standards of 2-OHBT, styrene, and substituted styrenes were purchased from Stability study of compound 9, 10, and 13 by HPLC
Compound 9 was prepared as a 5-mM DMSO stock solution at room temperature. Test solution (50 μM) was prepared in a 1.5 mL eppendorf tube by adding 10 μL of the DMSO stock solution into 990 μL PBS followed by incubation at 37 °C in a water bath. Samples for HPLC analysis were taken at random time points (n = 10) and subjected to HPLC analysis directly. Stability tests were in duplicates ( Figure S4 ). Kinetics study of esterase-triggered SO2 release of compound 10-13 by HPLC Stock solutions (500 M) of compounds 10-13 were prepared in DMSO at room temperature.
Porcine liver esterase (PLE, 18 unit/mg) was prepared as 0.1 unit/μL PBS stock solution. Test solution (50 μM with 5 unit/mL PLE) was prepared in an 8-mL glass vial by first adding 200 μL of the DMSO stock solution into 1700 μL of PBS and thoroughly mixed. Then to the solution was added 100 μL of the PLE stock solution followed by incubation at 37 °C in a water bath. 100 μL samples for analysis were taken every 10 minutes (n=12) and mixed with 300 μL ACN in a 1.5-mL eppendorf tube and stored at -80 °C. Frozen samples were thawed and centrifuged with benchtop micro-centrifuge at 14.5×10 3 rpm for 4 min to allow esterase and salt to precipitate. Supernatant was subjected to HPLC analysis. 2-OHBT, styrene, and substituted styrenes were used as standard and pre-tested for retention time. All kinetic runs were in triplicates. Microsoft Excel was used for plotting. Kinetics studies of the esterase-triggered SO2 release from compound 13 in 1% DMSO/PBS with 1 unit/mL PLE used the same method. Stock solutions were prepared accordingly ( Figure 1 Standard curve: 500 μM probe 14 DMSO stock solution was prepared at room temperature. NaHSO3 solutions of different concentrations were prepared in PBS. The test solution was prepared in a 4 mL (10 mm×10 mm) quartz cuvette by adding 300 μL probe DMSO stock solution into 2700 μL NaHSO3 solution.
Final solution contains 50 μM probe 14 and 10% DMSO. The test solution was sealed with a cap, thoroughly mixed, and incubated at room temperature for 2 min. Fluorescent emission at 465 nm was then recorded on a Shimadzu RF-5301PC fluorimeter. (λex=400 nm; slit width: ex: 5nm, em: 3 nm) Experiments were conducted in triplicates. Standard curves were fitted with Microsoft Excel 2016 ( Figure S7(A) ).
Studies of reaction kinetics: Stock solutions (1 mM) of compounds 10-13 were prepared in DMSO at room temperature. PLE (18 unit/mg) was prepared as 0.1 unit/μL PBS stock solution. Probe 14 was prepared as 1 mM DMSO stock solution. Test solution (50 μM prodrug with 50 μM probe and 5 unit/mL PLE) was prepared by adding 150 μL of the prodrug DMSO stock solution, 150 μL of the probe 14 DMSO stock solution, 2550 μL of PBS, and 150 μL PLE stock solution sequentially into a 4 mL (10 mm×10 mm) quartz cuvette. The test solution was sealed with a cap, and thoroughly mixed; and fluorescent emission at 465 nm was recorded every 10 minutes (n=13) (λex=400 nm; slit width: ex: 5nm, em: 3 nm). Fluorescence intensities obtained were converted to NaHSO3 concentrations using the standard curve described above. All runs were in triplicates ( Figure S7(B) ). 10 % fetal bovine serum and 1% penicillin-streptomycin at 37 °C with 5 % CO2. The media was changed every other day. Experiment was done within 10 passages of Hela cells. Cell imaging: HeLa cells were pre-seeded onto coverslips in 6-well plate a day before experiment. A 2-mM DMSO stock solution of probe 14 was prepared. Compound 13 was prepared as 20-mM DMSO stock solution. Cells were first treated with compound 13 to make a final concentration of 100 μM (0.5% DMSO). 400 μM NaHSO3 was used as a positive control. A mixture containing 100 μM 2-OHBT and 100 μM 2-methyl-1-phenyl-propene was used as the negative control. Cell only group was also used as negative controls. All final media contained 0.5% DMSO. The cells were incubated at 37 °C for 2 hours and washed with PBS once. 2 mL of fresh DMEM media was added into each well. The cells were then treated with probe 14 to give a final concentration of 10 μM. Cells were incubated for another 0.5 h at 37 °C. After washing twice with PBS, the cells were fixed with 4% paraformaldehyde for 30 min at room temperature. The cells were then washed once with PBS. Then 25 mM glycine in PBS was added to quench the extra formaldehyde. After storing at 4 °C overnight. The glycine solution was discarded. All coverslips were immersed in DI water and mounted onto glass slides using DAPI-free mounting media (ProLong Live Antifade Reagent; P36974). Fluorescent imaging was performed on a Zeiss fluorescent microscope using the DAPI channel (λex: 358 nm, λem: 461 nm).
